Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Systemic Lupus Erthematosus: early-phase trial registry
2 of 3 indexed Systemic Lupus Erthematosus trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 2 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Systemic Lupus Erthematosus: 3 US clinical trials tracked, 2 recruiting.
Systemic Lupus Erthematosus is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is LiveKidney.Bio, running 1 of these trials.
Enrollment posture brief
Registry condition systemic-lupus-erthematosus
OPEN 2 | RECR 67% | LATE 0 | EARLY 2 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)
Systemic Lupus Erthematosus lists 2 open slots (67% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Systemic Lupus Erthematosus on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Systemic Lupus Erthematosus is recruiting above its size-band peers.
2 of 3 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
Patient-Centered Assessment of Symptoms and Outcomes
National Center for Complementary and Integrative Health (NCCIH)
NCT03952624
UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients
LiveKidney.Bio
NCT06737380
Omalizumab for Lupus
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
NCT01716312
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Systemic Lupus Erthematosus records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Systemic Lupus Erthematosus trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Systemic Lupus Erthematosus page
3 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Systemic Lupus Erthematosus trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- LiveKidney.Bio sponsors the most Systemic Lupus Erthematosus trials on record, review their full trial history before evaluating a specific study. See LiveKidney.Bio's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Systemic Lupus Erthematosus condition card totals 3 registered trials; most-linked intervention Clinical laboratory evaluations - Biochemistry; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.